PRTO · Protara Therapeutics, Inc.
Market Cap
$226.04M
Shares
59.10M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-08-11 | — | |
| 8-K | 2026-06-29 | 2026-06-26 | |
| 8-K | 2026-06-15 | 2026-06-12 | |
| 8-K | 2026-05-13 | — | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| DEF 14A | 2026-04-28 | 2026-06-12 | |
| 8-K | 2026-03-30 | — | |
| 10-K | 2026-03-10 | 2025-12-31 | |
| 8-K | 2026-03-10 | — | |
| 8-K | 2026-02-24 | 2026-02-23 | |
| 8-K | 2025-12-15 | — | |
| 8-K | 2025-12-08 | 2025-12-04 | |
| 8-K | 2025-12-03 | — | |
| 8-K | 2025-11-19 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-08-11 | — | |
| 8-K | 2025-06-12 | 2025-06-11 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| 8-K | 2025-04-28 | 2025-04-26 | |
| DEF 14A | 2025-04-25 | 2025-06-11 | |
| 8-K | 2025-03-05 | — | |
| 10-K | 2025-03-05 | 2024-12-31 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-11 | 2024-12-09 | |
| 8-K | 2024-12-05 | — | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-06-10 | 2024-06-07 | |
| 8-K | 2024-05-02 | — | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | 2024-06-07 | |
| 8-K | 2024-04-05 | — | |
| 8-K | 2024-03-18 | — | |
| 8-K | 2024-03-13 | — | |
| 10-K | 2024-03-13 | 2023-12-31 | |
| 8-K | 2023-11-03 | — | |
| 10-Q | 2023-11-03 | 2023-09-30 | |
| 8-K | 2023-08-03 | — | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-06-08 | 2023-06-07 | |
| 10-Q | 2023-05-04 | 2023-03-31 | |
| 8-K | 2023-05-04 | — | |
| 8-K | 2023-05-02 | — | |
| 8-K | 2023-04-28 | — |
Showing 1–50 of 104 filings
Key facts
CIK
1359931
CUSIP
74365U107
13F (30d)
106 filings
106 filers
Visit website
Investor relations